Characterizing hub biomarkers for metabolic-induced endothelial dysfunction and unveiling their regulatory roles in EndMT through RNA sequencing and machine learning approaches.
Journal:
Frontiers in cardiovascular medicine
Published Date:
Jan 1, 2025
Abstract
BACKGROUND: Metabolic disorder and endothelial dysfunction (ED) are key events in the development and pathophysiology of atherosclerosis and are associated with an elevated risk of Cardiovascular disease (CVD). The pathophysiology remains incompletely understood.
Authors
Keywords
No keywords available for this article.